Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer.
Rulach RJ, McKay S, Neilson S, White L, Wallace J, Carruthers R, Lamb C, Cascales A, Marashi H, Glen H, Venugopal B, Sadoyze A, Sidek N, Russell JM, Alhasso A, Dodds D, Laskey J, Jones RJ, MacLeod N. Rulach RJ, et al. Among authors: lamb c. BJU Int. 2018 Feb;121(2):268-274. doi: 10.1111/bju.14025. Epub 2017 Oct 15. BJU Int. 2018. PMID: 28940952 Free article.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. James ND, et al. Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck.
Paterson C, Thomson MC, Caldwell B, Young R, McLean A, Porteous S, Clark S, Messow CM, Kean S, Grose D, Lamb C, Rizwannullah M, James A, Schipani S, Wilson C, Rulach R, Jones R. Paterson C, et al. Among authors: lamb c. Br J Oral Maxillofac Surg. 2019 Dec;57(10):1119-1125. doi: 10.1016/j.bjoms.2019.10.300. Epub 2019 Oct 29. Br J Oral Maxillofac Surg. 2019. PMID: 31672256 Free article. Clinical Trial.
Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Zhou S, Rulach R, Hendry F, Stobo D, James A, Dempsey MF, Grose D, Lamb C, Schipani S, Rizwanullah M, Wilson C, Lau YC, Paterson C. Zhou S, et al. Among authors: lamb c. Clin Oncol (R Coll Radiol). 2020 Oct;32(10):665-673. doi: 10.1016/j.clon.2020.05.018. Epub 2020 Jun 16. Clin Oncol (R Coll Radiol). 2020. PMID: 32561027
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Zhou S, Chan C, Rulach R, Dyab H, Hendry F, Maxfield C, Dempsey MF, James A, Grose D, Lamb C, Schipani S, Wilson C, Cheng Lau Y, Paterson C. Zhou S, et al. Among authors: lamb c. Oral Oncol. 2022 May;128:105870. doi: 10.1016/j.oraloncology.2022.105870. Epub 2022 Apr 18. Oral Oncol. 2022. PMID: 35447564
The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma.
Zhou S, Chan C, Lau YC, Rulach R, Dyab H, Hendry F, Wilson C, Schipani S, Lamb C, Grose D, James A, Maxfield C, Dempsey MF, Paterson C. Zhou S, et al. Among authors: lamb c. Clin Oncol (R Coll Radiol). 2023 Dec;35(12):e699-e707. doi: 10.1016/j.clon.2023.09.006. Epub 2023 Sep 22. Clin Oncol (R Coll Radiol). 2023. PMID: 37798198
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in Scotland.
Thapa A, Cowell A, Peters A, Noble DJ, James A, Lamb C, Grose D, Vohra S, Schipani S, Mactier K, Mackenzie J, Srinivasan D, Laws K, Moleron R, Niblock P, Soh FY, Paterson C, Wilson C. Thapa A, et al. Among authors: lamb c. Clin Oncol (R Coll Radiol). 2024 May;36(5):287-299. doi: 10.1016/j.clon.2024.02.004. Epub 2024 Feb 12. Clin Oncol (R Coll Radiol). 2024. PMID: 38395634
912 results